VREX vs. SLN, SVRA, ZYME, MLAB, AUNA, ENGN, DH, AVBP, SIBN, and QTRX
Should you be buying Varex Imaging stock or one of its competitors? The main competitors of Varex Imaging include Silence Therapeutics (SLN), Savara (SVRA), Zymeworks (ZYME), Mesa Laboratories (MLAB), Auna (AUNA), enGene (ENGN), Definitive Healthcare (DH), ArriVent BioPharma (AVBP), SI-BONE (SIBN), and Quanterix (QTRX). These companies are all part of the "medical" sector.
Silence Therapeutics (NASDAQ:SLN) and Varex Imaging (NASDAQ:VREX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends, community ranking and profitability.
Silence Therapeutics currently has a consensus target price of $57.25, indicating a potential upside of 148.91%. Varex Imaging has a consensus target price of $27.00, indicating a potential upside of 80.36%. Given Varex Imaging's higher possible upside, analysts clearly believe Silence Therapeutics is more favorable than Varex Imaging.
Silence Therapeutics has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. Comparatively, Varex Imaging has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.
Varex Imaging received 208 more outperform votes than Silence Therapeutics when rated by MarketBeat users. However, 71.88% of users gave Silence Therapeutics an outperform vote while only 63.46% of users gave Varex Imaging an outperform vote.
98.7% of Silence Therapeutics shares are held by institutional investors. 3.0% of Silence Therapeutics shares are held by company insiders. Comparatively, 5.2% of Varex Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
In the previous week, Silence Therapeutics had 8 more articles in the media than Varex Imaging. MarketBeat recorded 9 mentions for Silence Therapeutics and 1 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 0.69 beat Silence Therapeutics' score of 0.00 indicating that Silence Therapeutics is being referred to more favorably in the media.
Varex Imaging has a net margin of 4.90% compared to Varex Imaging's net margin of -131.44%. Silence Therapeutics' return on equity of 8.26% beat Varex Imaging's return on equity.
Varex Imaging has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.
Summary
Varex Imaging beats Silence Therapeutics on 9 of the 17 factors compared between the two stocks.
Get Varex Imaging News Delivered to You Automatically
Sign up to receive the latest news and ratings for VREX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VREX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Varex Imaging Competitors List
Related Companies and Tools
